ArticleBehaviour research and therapy2025
Early changes in passively sensed homestay predict depression symptom improvement during digital behavioral activation.
Article in Behaviour research and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Role of Digital Biomarkers in Physiological Signal-Based Depression Assessment: Systematic Review and Meta-Analysis.Journal of medical Internet research · 2026Pooled it
- Comparing personalized and population-based models for predicting momentary negative affect in internalizing disorders: A digital phenotyping study.Neuroscience applied · 2026Article
- Measuring activation during behavioral activation therapy: a proof-of-concept study using smartphone sensors and LLM-derived ratings in adolescents with anhedonia.NPP - digital psychiatry and neuroscience · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Digital behavioral activation (BA) is scalable, accessible, and efficacious for depression. However, some individuals do not improve during digital BA, and identifying non-responders early is critical for facilitating adaptive intervention approaches (e.g., stepped care). To explore whether passive sensing data might serve as early predictors of symptom change, we tested whether early changes in passively sensed behavioral targets of BA predicted depression symptom changes during app-based BA. Young adults (N = 47) with elevated depressive symptoms completed a 12-week trial of an app-based BA intervention, Vira. The Vira app provided BA psychoeducation, assessed self-reported daily mood, and used smartphone sensors to passively assess time spent at home (i.e., homestay), walking, stationary time, time in bed, bedtime, and waketime each day. We quantified early behavioral changes by fitting a multilevel growth model for each behavior over the first 2 weeks of the intervention. Models included a random slope reflecting each participant's average day-to-day change in that behavior. We extracted these slope estimates and tested whether they predicted depressive symptom (PHQ-8) change from pre-to post-intervention. We hypothesized that individuals with greater early changes in intervention-targeted behaviors would experience greater reductions in depressive symptoms. As hypothesized, individuals with greater early decreases in passively sensed homestay (i.e., reduced behavioral withdrawal) experienced a greater reduction in depressive symptoms by the end of treatment (b = 0.94, p = .025). Early changes in other behaviors did not significantly predict depressive symptom change (ps > .158). Passively monitoring early changes in homestay during app-based BA may support the early identification of individuals at risk of symptom persistence, thus providing earlier opportunities to adjust treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.